‘Don’t eat me’ upstart taps Takeda vet on path to the clinic; Greg Mayes leaves Antios for Canadian psychedelics player

Nenad Grmusa

Nenad Grmusa was “really happy” at Takeda, where he’d been for more than a decade in various R&D strategy and finance positions. However, the more he learned about DEM BioPharma, the more intrigued he became by cancer’s unexplored “don’t eat me” signals.

Jonathan...

Click to view original post